Fact checked byJohn C. Schoen, MA

Read more

July 23, 2024
1 min read
Save

Top in ID: Details of new HIV cure case; risk for long COVID declines

Fact checked byJohn C. Schoen, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A 60-year-old man in Germany became the seventh person to be considered potentially cured of HIV after receiving a stem cell transplant from a person with a genetic mutation that prevents infection.

While previous patients received stem cell transplants from donors with two copies of the CCR5-delta 32 mutation, this latest case was from a person with only one copy. Healio spoke with Christian Gaebler, MD, MSc, professor of translational immunology of viral infections at The Charité medical university and hospital in Berlin, about what this means for the future of HIV treatment and the search for a scalable cure.

HIV virus particles 3 NIAID
A man in Germany was potentially cured of HIV after he underwent a stem cell transplant from a donor with a rare genetic mutation. A half a dozen similar cases have been previously documented. Image: NIAID

It was the top story in infectious disease last week.

Another top story was about the risk for long COVID, which has declined since 2020 but is still “substantial,” according to Ziyad Al-Aly, MD, director of the Clinical Epidemiology Center and chief of research and education service at Veterans Affairs St. Louis Health Care System.

Read these and more top stories in infectious disease below:

Q&A: Seventh case of potential HIV cure comes with a twist

A seventh person has potentially been cured of HIV after receiving a stem cell transplant to treat blood cancer, researchers announced on the eve of the 25th International AIDS Conference. Read more.

Q&A: Risk for long COVID has declined, remains ‘substantial’

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported. Read more.

CDC: Resistant hospital infections increased 20% during COVID-19 pandemic

There was a combined 20% increase in six antimicrobial-resistant hospital infections in the United States during the COVID-19 pandemic, and the number of clinical cases of Candida auris increased fivefold, according to the CDC. Anurag N. Malani, MD, an epidemiologist who was uninvolved in the CDC study, discussed the findings in a perspective. Read more.

CDC confirms new bird flu cases in Colorado poultry workers

The CDC said it has confirmed four new cases of highly pathogenic avian influenza in Colorado poultry workers and is aware of a fifth presumptive-positive case. Read more.

Long-acting PrEP acceptable, feasible among men, women in trial

Long-acting injectable PrEP is feasible and acceptable to both men and women, according to a study presented at the AIDS 2024 meeting in Munich. Read more.